Comparison
11q Partial Monosomy Syndrome C0795841 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Clinical comparison between 11q Partial Monosomy Syndrome and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete CN042980 for differential diagnosis and treatment planning.
11q Partial Monosomy Syndrome C0795841
A chromosomal disorder from missing genetic material on chromosome 11. It typically causes developmental delays, intellectual disability, and facial differences. Care focuses on symptom management and developmental interventions.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
A rare enzyme deficiency affecting hormone production, leading to low sex hormones and elevated blood pressure. Lifelong hormone replacement therapy is typically needed. Ongoing medical monitoring helps manage associated health concerns.
6 comparison axes
Onset
11q Partial Monosomy Syndrome C0795841
0-0
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
0-null
Onset patterns differ
Severity
11q Partial Monosomy Syndrome C0795841
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
severe
Different severity levels
Chronic
11q Partial Monosomy Syndrome C0795841
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Chronic
Differing course
Communicable
11q Partial Monosomy Syndrome C0795841
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
No
Different transmission
Body System
11q Partial Monosomy Syndrome C0795841
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Same/different system
Category
11q Partial Monosomy Syndrome C0795841
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Different category
Bottom line
11q-partial-monosomy-syndrome-C0795841 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-complete-CN042980 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11q Partial Monosomy Syndrome C0795841 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Discriminating power |
|---|---|---|---|
| Development | Developmental delay and intellectual disability are typical described features. | Development is not the defining feature in the supplied description. | High |
| Blood pressure | Hypertension is not described as a core feature. | Elevated blood pressure is a characteristic concern. | High |
| Physical appearance | Facial differences may be present. | Facial differences are not the primary described feature. | Moderate |
When to favor each condition
Choose 11q Partial Monosomy Syndrome C0795841 when
Confirmed missing chromosome 11 material
A chromosomal finding directly supports this diagnosis.
High
Congenital developmental concerns
Early developmental delay and facial differences fit the supplied profile.
Moderate
Need for developmental support
Care centers on symptom management and developmental interventions.
Moderate
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 when
Low sex hormones with hypertension
This combination matches the described endocrine pattern.
High
Suspected steroid enzyme deficiency
Specialist endocrine and genetic evaluation can distinguish it.
Moderate
Need for hormone replacement
Lifelong replacement is typically described, without specifying doses here.
Moderate
How key tests differ
| Test | 11q Partial Monosomy Syndrome C0795841 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show partial loss of chromosome 11 material. | No characteristic chromosomal deletion is expected. | A chromosomal result supports the left condition but does not assess enzyme function. |
| Steroid hormone profile | No diagnostic hormone pattern is established here. | Abnormal sex-hormone and blood-pressure-related steroid findings are expected. | Exact cutoffs are not supplied and require clinician interpretation. |
| CYP17A1 genetic testing | Not the primary confirmatory test. | May identify causative variants when clinically indicated. | Genetic results should be interpreted with endocrine findings. |
Prognosis comparison
11q Partial Monosomy Syndrome C0795841
- Outcome
- Chronic congenital condition with variable developmental impact.
- Factors
- Extent of missing material and available supports may influence needs.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
- Outcome
- Chronic endocrine condition requiring long-term monitoring.
- Factors
- Hormone balance and blood-pressure control are important, but exact outcomes are not established here.
Time frame: Lifelong for both; precise prognosis cannot be determined from these data.
Diagnosis confirmation, complications, and access to specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Developmental and learning difficulties may be prominent. Not established as a primary complication from the supplied data. Support needs should be individualized. |
| Blood pressure | Not described as a defining complication. Hypertension requires ongoing monitoring. No treatment thresholds are provided here. |
| Sexual development | Not the central feature in the supplied description. Low sex hormones may affect puberty and reproductive health. Specific outcomes vary and need specialist assessment. |
Patient education highlights
- HighDifferent causes
One is a chromosomal condition; the other is a hormone-production enzyme deficiency.
- HighFollow-up
Both need ongoing specialist care, but monitoring targets differ.
- MediumTransmission
Neither condition is communicable.